source
- FDA commissioner touts real-time trial monitoring to cut drug development dead timeThe Food and Drug Administration announced a new approach that will let regulators view clinical trial endpoints as they happen, using cloud‑based data streams. The move targets the long delays th…
- Supreme Court to Hear Arguments on “Skinny Labeling” Case Impacting Generic Drug AccessThe U.S. Supreme Court scheduled oral arguments for Wednesday on a case concerning “skinny labeling,” a practice used by generic drug makers. Skinny labeling involves seeking approval to market a…